7Baggers
 lyra therapeutics receives nasdaq deficiency letter  MSN Fri, 12 Sep 2025 00:09:44 GMT
 lyra therapeutics receives nasdaq deficiency letter  MSN Thu, 11 Sep 2025 14:46:43 GMT
 lyra therapeutics posts corporate presentation on lyr-210  The Globe and Mail Fri, 05 Sep 2025 07:00:00 GMT
 lyra therapeutics (lyra) stock price, news & analysis  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 Lyra Therapeutics Posts Corporate Presentation on LYR-210  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 Lyra Therapeutics : Corporate Presentation - September 2025 (ffc804)  MarketScreener Thu, 04 Sep 2025 07:00:00 GMT
 lyra therapeutics posts 85% q2 loss drop  AOL.com Wed, 27 Aug 2025 19:57:11 GMT

Lyra Therapeutics, Inc
(NASDAQ:LYRA) 

LYRA stock logo

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver...

Founded: 2005
Full Time Employees: 33
CEO: Maria Palasis  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends